» Articles » PMID: 23133676

Total Beta-adrenoceptor Knockout Slows Conduction and Reduces Inducible Arrhythmias in the Mouse Heart

Overview
Journal PLoS One
Date 2012 Nov 8
PMID 23133676
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Beta-adrenoceptors (β-AR) play an important role in the neurohumoral regulation of cardiac function. Three β-AR subtypes (β(1), β(2), β(3)) have been described so far. Total deficiency of these adrenoceptors (TKO) results in cardiac hypotrophy and negative inotropy. TKO represents a unique mouse model mimicking total unselective medical β-blocker therapy in men. Electrophysiological characteristics of TKO have not yet been investigated in an animal model.

Methods: In vivo electrophysiological studies using right heart catheterisation were performed in 10 TKO mice and 10 129SV wild type control mice (WT) at the age of 15 weeks. Standard surface ECG, intracardiac and electrophysiological parameters, and arrhythmia inducibility were analyzed.

Results: The surface ECG of TKO mice revealed a reduced heart rate (359.2±20.9 bpm vs. 461.1±33.3 bpm; p<0.001), prolonged P wave (17.5±3.0 ms vs. 15.1±1.2 ms; p = 0.019) and PQ time (40.8±2.4 ms vs. 37.3±3.0 ms; p = 0.013) compared to WT. Intracardiac ECG showed a significantly prolonged infra-Hisian conductance (HV-interval: 12.9±1.4 ms vs. 6.8±1.0 ms; p<0.001). Functional testing showed prolonged atrial and ventricular refractory periods in TKO (40.5±15.5 ms vs. 21.3±5.8 ms; p = 0.004; and 41.0±9.7 ms vs. 28.3±6.6 ms; p = 0.004, respectively). In TKO both the probability of induction of atrial fibrillation (12% vs. 24%; p<0.001) and of ventricular tachycardias (0% vs. 26%; p<0.001) were significantly reduced.

Conclusion: TKO results in significant prolongations of cardiac conduction times and refractory periods. This was accompanied by a highly significant reduction of atrial and ventricular arrhythmias. Our finding confirms the importance of β-AR in arrhythmogenesis and the potential role of unspecific beta-receptor-blockade as therapeutic target.

Citing Articles

Fluoxetine promotes IL-10-dependent metabolic defenses to protect from sepsis-induced lethality.

Gallant R, Sanchez K, Joulia E, Snyder J, Metallo C, Ayres J Sci Adv. 2025; 11(7):eadu4034.

PMID: 39951524 PMC: 11827869. DOI: 10.1126/sciadv.adu4034.


Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD).

Hasin T, Davarashvili I, Michowitz Y, Farkash R, Presman H, Glikson M J Clin Med. 2021; 10(8).

PMID: 33920719 PMC: 8073338. DOI: 10.3390/jcm10081753.


Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.

Stockigt F, Eichhorn L, Beiert T, Knappe V, Radecke T, Steinmetz M PLoS One. 2020; 15(3):e0228913.

PMID: 32126091 PMC: 7053759. DOI: 10.1371/journal.pone.0228913.


Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation.

Jungen C, Scherschel K, Flenner F, Jee H, Rajendran P, De Jong K Am J Physiol Heart Circ Physiol. 2019; 317(6):H1328-H1341.

PMID: 31625779 PMC: 6962614. DOI: 10.1152/ajpheart.00249.2019.


Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System.

Jungen C, Scherschel K, Bork N, Kuklik P, Eickholt C, Kniep H J Vis Exp. 2018; (135).

PMID: 29889210 PMC: 6101334. DOI: 10.3791/57617.


References
1.
Friedberg C, Donoso E, STEIN W . NONSURGICAL ACQUIRED HEART BLOCK. Ann N Y Acad Sci. 1964; 111:835-47. DOI: 10.1111/j.1749-6632.1964.tb53151.x. View

2.
Miller C, Roe M, Mulgund J, Hoekstra J, Santos R, Pollack Jr C . Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med. 2007; 120(8):685-92. DOI: 10.1016/j.amjmed.2007.04.016. View

3.
Dixon R, Kobilka B, Strader D, Benovic J, Dohlman H, Frielle T . Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature. 1986; 321(6065):75-9. DOI: 10.1038/321075a0. View

4.
Rohrer D, Chruscinski A, Schauble E, Bernstein D, Kobilka B . Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem. 1999; 274(24):16701-8. DOI: 10.1074/jbc.274.24.16701. View

5.
Wallukat G . The beta-adrenergic receptors. Herz. 2002; 27(7):683-90. DOI: 10.1007/s00059-002-2434-z. View